Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Danforth DN Jr.

Breast Cancer (Auckl). 2016 Aug 17;10:109-46. doi: 10.4137/BCBCR.S39384. eCollection 2016. Review.

2.

Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome.

Menendez JA, Folguera-Blasco N, Cuyàs E, Fernández-Arroyo S, Joven J, Alarcón T.

Oncotarget. 2016 Mar 15;7(11):11959-71. doi: 10.18632/oncotarget.7867.

3.

BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer.

Sedic M, Kuperwasser C.

Cell Cycle. 2016;15(5):621-7. doi: 10.1080/15384101.2016.1141841.

PMID:
26822887
4.

Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.

Bayraktar S, Qiu H, Liu D, Shen Y, Gutierrez-Barrera AM, Arun BK, Sahin AA.

Biomark Cancer. 2015 Aug 18;7:39-49. doi: 10.4137/BIC.S29716. eCollection 2015.

5.

An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer.

Danforth DN, Warner AC, Wangsa D, Ried T, Duelli D, Filie AC, Prindiville SA.

Breast Cancer (Auckl). 2015 Jun 8;9:31-40. doi: 10.4137/BCBCR.S23577. eCollection 2015.

6.

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.

Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, Gustin JP, Cidado J, Wang GM, Cosgrove D, Cochran R, Jelovac D, Higgins MJ, Arena S, Hawkins L, Lauring J, Gross AL, Heaphy CM, Hosokawa Y, Gabrielson E, Meeker AK, Visvanathan K, Argani P, Bachman KE, Park BH.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17773-8. doi: 10.1073/pnas.1110969108. Epub 2011 Oct 10.

7.

Novel molecular markers of malignancy in histologically normal and benign breast.

Nasir A, Chen DT, Gruidl M, Henderson-Jackson EB, Venkataramu C, McCarthy SM, McBride HL, Harris E, Khakpour N, Yeatman TJ.

Patholog Res Int. 2011;2011:489064. doi: 10.4061/2011/489064. Epub 2011 Jul 10.

8.

Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.

Graham K, Ge X, de Las Morenas A, Tripathi A, Rosenberg CL.

Clin Cancer Res. 2011 Jan 15;17(2):236-46. doi: 10.1158/1078-0432.CCR-10-1369. Epub 2010 Nov 8.

9.

Malignant tumors and forensics--dilemmas and proposals.

Budimlija Z, Lu C, Axler-DiPerte G, Seifarth J, Popiolek D, Fogt F, Prinz M.

Croat Med J. 2009 Jun;50(3):218-27.

10.

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers.

Clarke CL, Sandle J, Jones AA, Sofronis A, Patani NR, Lakhani SR.

Br J Cancer. 2006 Aug 21;95(4):515-9. Epub 2006 Aug 1.

11.

Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.

Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, Eng C.

Am J Hum Genet. 2006 Jun;78(6):961-72. Epub 2006 Apr 12.

Items per page

Supplemental Content

Write to the Help Desk